CorrespondenceGlutathione S-transferase as a major autoantigen in anti-SLA–positive autoimmune hepatitis
References (9)
- et al.
Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis
Gastroenterology
(1998) - et al.
Serological definition of new subgroup of patients with autoimmune chronic active hepatitis
Lancet
(1987) - et al.
Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen
Lancet
(1987) - et al.
Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies
J Hepatol
(1990)
Cited by (21)
Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis
2004, Journal of AutoimmunityNew autoantibodies and autoantigens in autoimmune hepatitis
2002, Clinics in Liver DiseaseAntibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis
2002, American Journal of GastroenterologyCitation Excerpt :Antibodies to actin have greater diagnostic specificity than SMAs but less sensitivity for autoimmune hepatitis, and a standardized assay for their detection is unavailable (12–14). Antibodies to soluble liver antigen (anti-SLAs) (15) and antibodies to liver pancreas (anti-LPs) (16) have identical reactivities (17), and they are highly specific markers of autoimmune hepatitis (18). We have shown previously that these antibodies, now designated as anti-SLA/LPs, occur in at least 11% of patients with type 1 autoimmune hepatitis (19) and that they are useful in securing the diagnosis in individuals who lack ANAs and SMAs (18, 19).
Autoantibodies in liver disease
2001, GastroenterologyCitation Excerpt :Their major clinical role may be in the evaluation and reclassification of cryptogenic chronic hepatitis.47,48 Anti-LP was initially described independent of anti-SLA,46 and only recently has its identity to anti-SLA been recognized.49,124 Consequently, anti-LP can be expected to have the same clinical utility as anti-SLA, and the designation anti-SLA/LP replaces the previous terms anti-LP and anti-SLA.
Antibodies to soluble liver antigen: An additional marker in type 1 auto-immune hepatitis
2000, Journal of Hepatology